Mediwound Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +132.0% | +159.2% | +60.2% | +36.3% | +834.7% | -31.5% | +9.2% | +11.5% | -29.5% | +8.2% | -16.1% | |
| – | -9.6% | -14.3% | -26.9% | +32.3% | +467.5% | +20.0% | +5.4% | -11.1% | +13.3% | +16.4% | -22.1% | |
| – | – | – | – | +43.0% | +1,418.7% | -62.2% | +16.2% | +50.1% | -72.8% | -26.4% | +23.5% | |
| – | +12.6% | +17.4% | -22.7% | -25.4% | +22.0% | +54.9% | +33.2% | -0.7% | -26.7% | +18.9% | +61.3% | |
| – | -15.6% | +1.9% | -7.3% | +0.8% | +33.0% | +41.2% | +9.9% | +7.5% | +2.9% | +13.3% | +3.5% | |
| – | +2.2% | +1.3% | -25.3% | -63.9% | +192.9% | +6.1% | +22.0% | +4.2% | -8.4% | +15.4% | +29.6% | |
| – | – | – | – | – | – | -296.8% | – | – | – | – | – | |
| – | +678.9% | +90.8% | -2.4% | +7.9% | -76.8% | -3.4% | -16.5% | -3.0% | +106.8% | +67.5% | +18.2% | |
| – | – | – | – | – | – | -549.0% | – | – | – | – | – | |
| – | – | -247.5% | – | -214.5% | – | – | -91.7% | +188.9% | +137.2% | -67.0% | +177.0% | |
| – | – | – | – | – | – | -285.6% | – | – | – | – | – | |
| – | – | – | – | – | – | -277.6% | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.